about
Targeting selectins and selectin ligands in inflammation and cancerDifferential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMPThe C-terminal CGHC motif of protein disulfide isomerase supports thrombosis.Role of sulfatide in normal and pathological cells and tissuesEffect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factorsSELP and SELPLG genetic variation is associated with cell surface measures of SELP and SELPLG: the Atherosclerosis Risk in Communities Carotid MRI StudyPlatelet response as a sentinel marker of toll-like receptor 4 activation in mice.Aggregation and microparticle production through toll-like receptor 4 activation in platelets from recently menopausal women.Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.Aspirin: pharmacology and clinical applicationsSpecific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) studyHigher soluble P-selectin is associated with chronic venous insufficiency: the San Diego Population Study.Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation.A platelet-inspired paradigm for nanomedicine targeted to multiple diseases.Tissue Factor Expression on Platelet Surface during Preparation and Storage of Platelet Concentrates.Platelet binding and phagocytosis by macrophages.Markers of inflammation and influence of nitric oxide on platelet activation in the course of ulcerative colitisReduction of blood coagulation and monocyte-platelet interaction following the use of a minimal extracorporeal circulation system (Synergy) in coronary artery bypass grafting (CABG).Plasma concentration of selected biochemical markers of endothelial dysfunction in women with various severity of chronic venous insufficiency (CVI)-A pilot study.Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products.Using affinity capillary electrophoresis and computational models for binding studies of heparinoids with p-selectin and other proteins.Antiplatelet drugs
P2860
Q24658204-C863B9D0-2758-40B1-AEEB-5EF8E8C7CEEEQ24685943-60F79E53-C011-4C38-9037-B2CD3E5E663FQ27332350-26E77847-19DE-4AF5-A990-8D9A05DDE004Q28267288-6A4942B9-1F94-4E48-B3DA-EAD428D5E964Q28287127-D99F675C-12A3-457A-9084-3BB54613D697Q33614699-476220DD-39B8-4E7F-A0E0-660E2D1C474DQ34298384-ACE37BCF-F423-46A1-8C80-5903A70FE516Q34491825-48CA8AB0-DC51-49B8-92F4-44240C1910B9Q35324757-F0DB7224-57E9-4556-91F5-2E7D217B1408Q35608778-5B9A7E46-F08C-429B-BCFB-2D995A0DA12CQ36328204-1B1B6338-FBAA-4A7A-A8C2-E3ACF0176665Q36328521-D53F6D82-C6AB-438E-802A-795568F3C203Q37671483-578EC7D1-D070-424C-9492-02548F5EB416Q38145567-9C3F953A-6616-4709-814D-ADE4117385DEQ40204023-3E5A15E5-3FAA-4D54-86A8-1C53D241369BQ40239468-BF3A0563-07A8-4082-B373-6CAF2720CEE4Q42186470-02D82268-E7F6-4398-AD6C-FD89FD74C7C9Q46371616-7A765697-58DD-4821-A6AA-A7DC9FE4708DQ49169795-F55E56EF-CFDA-481C-9615-A6A45B25F338Q49346082-4B43A56D-72A8-4060-8C9B-DB2AD3E01B0FQ51113481-CC1B327E-CD67-4834-9C77-BDDFF8E9FF18Q58481433-C0101944-AADE-4C05-83D9-BF85B45A2E01
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
P-selectin in arterial thrombosis.
@ast
P-selectin in arterial thrombosis.
@en
type
label
P-selectin in arterial thrombosis.
@ast
P-selectin in arterial thrombosis.
@en
prefLabel
P-selectin in arterial thrombosis.
@ast
P-selectin in arterial thrombosis.
@en
P1476
P-selectin in arterial thrombosis.
@en
P2093
Thiagarajan P
P2888
P304
P356
10.1007/S00392-004-0146-5
P577
2004-11-01T00:00:00Z